Jubilant Life Science Ltd has got the final approval for its generic version of non-steroidal anti-inflammatory drug, Indocin from the US health regulator. The company...
The US health regulator has provided its final approval to the drug firm Jubilant Life Sciences for Celecoxib capsules that are used in treating osteoarthiritis...
Jubilant Life Sciences is seeking shareholders approval through postal ballot/e-voting for raising up to Rs 1,000 crore by issuing non-convertible debentures (NCDs) on private placement...
Jubilant Life Science has got the US health regulator’s approval for Telmisartan Tablets that are used in the treatment of hypertension, in the American market....
On Tuesday, Jubilant Life Science said that it has received the US health regulator’s approval for its generic version of Merck’s acute migraine treatment medicine,...
Jubilant Life Science has received US health regulator’s approval to market Indomethacin capsule, that are used for treating pains. Jubilant Life Science said in a...